Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2024 09:21 ET | Source: Wohl & Fruchter LLP

ALIM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Alimera Sciences to ANI Pharmaceuticals

We are investigating the fairness of the proposed sale of Alimera Sciences to ANI Pharmaceuticals for $5.50 per share in cash, plus a CVR.
August 10, 2016 16:01 ET | Source: Alimera Sciences, Inc.

Alimera Sciences Proposes Public Offering of Common Stock

ATLANTA, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a pharmaceutical company that specializes in research, development and commercialization of...
August 09, 2016 07:30 ET | Source: Alimera Sciences, Inc.

Alimera Sciences announces clinical presentations and sponsored Symposia at ASRS 2016 Annual meeting

ATLANTA, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today...
February 18, 2016 07:30 ET | Source: Alimera Sciences, Inc.

Alimera Sciences to Report Fourth Quarter 2015 Financial Results on March 2, 2016

ALPHARETTA, Ga., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today...